- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GILD
Recent news which mentions GILD
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
From Benzinga
From Benzinga
From MarketWatch
These 2 Stock Winners Topped Apple's Big Gains Friday
October 28, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
From Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
From Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
From Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
October 28, 2022
From Benzinga
WHO panel says no evidence yet that new omicron subvariants are more risky than others that are circulating
October 28, 2022
Tickers
GILD
Tags
GILD
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
From Benzinga
From Benzinga
From Benzinga
Gilead Sciences (GILD) Q3 2022 Earnings Call Transcript
October 27, 2022
Tickers
GILD
From Motley Fool
From MarketWatch
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
From InvestorPlace
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
October 21, 2022
Tickers
GILD
From Benzinga
From Benzinga
US Sends Gilead's COVID-19 Antiviral To Safeguard Health Workers In Uganda Ebola Outbreak
October 19, 2022
Tickers
GILD
From Benzinga
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of Care
October 18, 2022
Tickers
GILD
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
From Motley Fool
Want to Collect 4% in Dividends Every Month? Buy These 3 Stocks
October 12, 2022
From Motley Fool
4 Biotech Stocks With Huge Incoming Catalysts
October 12, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.